BioGend Therapeutics Co Ltd (ROCO:6733)
NT$ 36.1 -0.1 (-0.28%) Market Cap: 4.49 Bil Enterprise Value: 3.86 Bil PE Ratio: 0 PB Ratio: 5.10 GF Score: 54/100

BioGend Therapeutics Co Ltd (ROCO:6733) Transcripts

    • 1